Further elucidation of this pathway may enable the use of ECRG4 expression to identify patients at increased risk of diabetic complications, such as severe infections and chronic wounds, as well as identify novel therapeutic targets for preventing these devastating complications. The gene discussed is ECRG4; the disease is infection.